This region includes the countries of North and South America and island nations in their adjacent waters. This region includes three of the largest countries in the world, as well as some of the smallest.
While this region is virtually free of some infectious diseases, including poliomyelitis and measles, many other infectious diseases remain endemic and epidemic. In January 2010, Haiti experienced a devastating earthquake that damaged and destroyed several buildings, including hospitals. The country continues to face many health challenges, particularly the spread of cholera in the aftermath of the earthquake. The region is currently under threat from dengue and chikungunya.
NIAID priorities in the Americas include research on HIV/AIDS, influenza, tuberculosis, malaria, dengue, chikungunya, and neglected tropical diseases, particularly Chagas disease which is endemic only in Central and South America. All NIAID activities in this region aim to improve understanding of these diseases and to translate new discoveries into methods of preventing, diagnosing, and treating them.
- Costa Rica
- Dominican Republic
- St. Kitts and Nevis
- Trinidad and Tobago
- United States
”Global Health Challenges and Collaborative Opportunities in Arbovirus Research” Workshop, November 30 – December 3, 2015, Manaus, Brazil
The U.S. National Institutes of Health (NIH) and the Oswaldo Cruz Foundation (Fiocruz) have a long-standing cooperation in the areas of tropical diseases including arboviruses of the amazon. The goals for this workshop included exchanging ideas and presenting research findings by U.S. and Brazilian researchers, encouraging partnerships and development of joint projects, and learning about and understanding research capabilities.
Chikungunya Meeting, June 30 – July 2, 2015, Rockville, Maryland, USA
The goals of this workshop included sharing knowledge about chikungunya disease, epidemiology, and pathogenesis; assessing the chikungunya epidemic risk throughout the Americas; identifying critical gaps in knowledge, technologies, and research infrastructure needed to interrupt the epidemic; and discussing potential collaborative research opportunities to address the prevention, diagnosis, treatment, and control of chikungunya disease.